Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -8.93% is 15% below its 5-year average of -7.78%, around the middle of its 5-year range (-18.31%–-1.29%).
209.00% below its 12-month average of -2.89%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -4.14%.
RETURN ON ASSETS (ROA)
-8.93%
RETURN ON ASSETS (ROA) AVG TTM
-2.89%
RETURN ON ASSETS (ROA) AVG 3Y
-5.64%
RETURN ON ASSETS (ROA) AVG 5Y
-7.78%
RETURN ON ASSETS (ROA) AVG 10Y
-22.68%
RETURN ON ASSETS (ROA) AVG 15Y
-31.94%
RETURN ON ASSETS (ROA) AVG 20Y
-43.25%
CURRENT VS TTM AVG
-209.00%
CURRENT VS 3Y AVG
-58.33%
CURRENT VS 5Y AVG
-14.71%
CURRENT VS 10Y AVG
+60.63%
CURRENT VS 15Y AVG
+72.04%
CURRENT VS 20Y AVG
+79.35%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+72.30%
vs the sector median at left
Harrow Health, Inc.
Market Cap
$1.13B
Return on Assets (ROA)
-8.93%
TTM Avg
-2.89%
3Y Avg
-5.64%
5Y Avg
-7.78%
Market Cap
$1.13B
Return on Assets (ROA)
0.69%
TTM Avg
1.67%
3Y Avg
0.18%
5Y Avg
-3.47%
Market Cap
$1.13B
Return on Assets (ROA)
-57.23%
TTM Avg
-57.23%
3Y Avg
-57.23%
5Y Avg
-57.23%
Market Cap
$1.14B
Return on Assets (ROA)
4.50%
TTM Avg
8.06%
3Y Avg
9.38%
5Y Avg
7.83%
Market Cap
$1.14B
Return on Assets (ROA)
-14.35%
TTM Avg
-48.83%
3Y Avg
-54.71%
5Y Avg
-49.10%
Market Cap
$1.11B
Return on Assets (ROA)
-117.65%
TTM Avg
-69.65%
3Y Avg
-52.63%
5Y Avg
-41.83%
Market Cap
$1.11B
Return on Assets (ROA)
-5.49%
TTM Avg
-16.57%
3Y Avg
-16.38%
5Y Avg
-11.43%
Market Cap
$1.10B
Return on Assets (ROA)
0.81%
TTM Avg
-17.43%
3Y Avg
-5.68%
5Y Avg
0.08%
Market Cap
$1.10B
Return on Assets (ROA)
-50.25%
TTM Avg
-43.65%
3Y Avg
-37.07%
5Y Avg
-37.07%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harrow Health, Inc. (HROW) | $1.13B | -8.93% | -2.89% | -5.64% | -7.78% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 0.69% | 1.67% | 0.18% | -3.47% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | -57.23% | -57.23% | -57.23% | -57.23% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 4.50% | 8.06% | 9.38% | 7.83% |
| Nektar Therapeutics (NKTR)vs › | $1.14B | -14.35% | -48.83% | -54.71% | -49.10% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | -117.65% | -69.65% | -52.63% | -41.83% |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | -5.49% | -16.57% | -16.38% | -11.43% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.81% | -17.43% | -5.68% | 0.08% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | -50.25% | -43.65% | -37.07% | -37.07% |
| OPKO Health, Inc. (OPK)vs › | $1.09B | -3.98% | -7.05% | -9.66% | -6.44% |
ROA
-8.9%
ROE
-244.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -1.29% |
| 2024-12-31 | -4.49% |
| 2023-12-31 | -7.83% |
| 2022-12-31 | -8.95% |
| 2021-12-31 | -18.31% |
| 2020-12-31 | -5.84% |
| 2019-12-31 | 0.28% |
| 2018-12-31 | 29.57% |
| 2017-12-31 | -50.11% |
| 2016-12-31 | -70.05% |
| 2015-12-31 | -112.51% |
| 2014-12-31 | -98.79% |
| 2013-12-31 | -48.49% |
| 2012-12-31 | -50.29% |
| 2011-12-31 | -592.70% |
| 2010-12-31 | -718.44% |
| 2009-12-31 | -272.35% |
| 2008-12-31 | -61.92% |
| 2007-12-31 | -101.04% |
| 2006-12-31 | -168.43% |
| 2005-12-31 | 0.00% |
